ResMed Inc. announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was USD 800.011 million compared to USD 736.157 million a year ago. Operating income was USD 221.716 million compared to USD 197.809 million a year ago. Net income was USD 179.514 million compared to USD 160.554 million a year ago. Basic earnings per share from continuing operations was USD 1.24 compared to USD 1.11 a year ago. Diluted earnings per share from continuing operations was USD 1.23 compared to USD 1.1 a year ago. For the half year, sales was USD 1,551.955 million compared to USD 1,417.213 million a year ago. Operating income was USD 438.612 million compared to USD 368.912 million a year ago. Net income was USD 357.886 million compared to USD 280.702 million a year ago. Basic earnings per share from continuing operations was USD 2.47 compared to USD 1.95 a year ago. Diluted earnings per share from continuing operations was USD 2.45 compared to USD 1.93 a year ago.